Aims: Every year, over 200 000 individuals undergo bariatric surgery for the treatment of extreme obesity in the United States. Several retrospective studies describe the occurrence of orthostatic intolerance (OI) syndrome after bariatric surgery. However, the incidence of this syndrome remains unknown.
| INTRODUCTION
Obesity afflicts over 117 million American adults, and the cost of its care amounts to over $340 billion annually.
1 Bariatric surgery is the most effective and only treatment modality for obesity that results in sustained weight loss and improvement of glucose control in type 2 diabetes mellitus (T2DM) and cardiovascular risk factors. 2, 3 It is estimated that over 200 000 patients in the United States undergo bariatric surgery every year, 4 and therefore, it becomes increasingly important to understand the long-term consequences of this operation. In this context, small case series studies [5] [6] [7] have documented the presence of new-onset orthostatic intolerance (OI) in postoperative bariatric surgery patients.
OI is a rare and chronic disabling condition characterized by dizziness, lightheadedness, and syncope on standing that improve after sitting or lying down. 8 This disorder significantly reduces the quality of life, 9 and in severe cases, it requires the use of pressor agents to control the presyncopal symptoms.
The diagnosis of OI is challenging and requires the identification of chronic pre-syncopal symptoms on standing not related to the use of medications or conditions associated with blood volume depletion.
Hence, it is not surprising that previous studies that examined the long-term consequences of bariatric surgery did not report OI as significant adverse events. 10 The burden of OI in patients that underwent bariatric surgery is unknown.
The goal of this study was to estimate the incidence of OI and its temporal relationship with weight changes among patients who underwent bariatric surgery. For this purpose, the authors assembled a large retrospective database from a high-volume bariatric surgery centre in the Southeast United States. OI cases were ascertained using a protocol developed by the Vanderbilt Autonomic Dysfunction Center (VADC), a national referral centre for patients with OI, and the cases were adjudicated after an exhaustive chart review.
| MATERIALS AND METHODS

| Data sources
The current study was conducted using the Vanderbilt Metabolic and Bariatric Surgery Quality, Efficacy, and Safety Database (VMBSD), which is a prospective de-identified registry that includes records of all patients who have undergone bariatric surgery at Vanderbilt University Medical Center (VUMC). The data not available in the VMBSD were extracted through medical chart review using the Vanderbilt Synthetic Derivative (SD), a de-identified database containing additional clinical and procedural information derived from Vanderbilt's electronic medical records system. 11 The SD database search interface allows users to find basic clinical and demographic data, such as ICD 9
and 10 codes, current procedural terminology (CPT) codes, medications, laboratory values, age, gender, and vitals in the records. Records in both databases can be linked using internal identifiers. The Vanderbilt Institutional Review Board approved the study.
| Patients with bariatric surgery
Within VMBSD, data were queried from 1997 to 2017 to identify patients who underwent bariatric surgery on the basis of CPT codes.
Patients who had undergone Roux-en-Y gastric bypass (RYGB) were identified through CPT codes 43644, 43645, 43846, or 43847, and patients who had undergone vertical sleeve gastrectomy (VSG) were identified through CPT code 43775.
| Review of medical records
The SD medical records were queried of bariatric surgery patients for symptoms of OI and identified cases in two stages. In the first stage, potential patients with OI were identified on the basis of recorded ICD9 or ICD10 diagnosis codes for dizziness, orthostatic hypotension, tachycardia, bradycardia, or syncope coded after the operation (Appendix S1). In the second stage, the records of these potential patients with OI were reviewed via natural language processing for final determination of OI diagnosis.
| Definition of OI
The VADC, a national referral centre for autonomic disorders of blood pressure regulation, developed an adjudication protocol. The protocol was designed to identify OI patients on the basis of chart review following published guidelines. 8 During the chart review, OI was defined as the presence of symptoms like dizziness, lightheadedness, and syncope upon standing at least 30 days after the operation with a duration of at least 3 months, with haemodynamic changes (orthostatic hypotension, tachycardia, and bradycardia). Participants with pathological conditions reported preoperatively or postoperatively that could explain the occurrence of OI symptoms as previously reported by our group (ie, haemorrhage, dehydration, and anaemia) were excluded. 12 Similarly, those on new medications or changes in the dose of medications known to cause or worsen OI (diuretics, alpha-1 blockers, or vasodilators) were excluded.
For participants with confirmed postoperative, new-onset OI, we defined the time of diagnosis to be the earliest time when all the adjudication conditions above were fulfilled. Patients whose time of diagnosis exceeded 72 months post operation were deemed to have developed OI for reasons unrelated to the bariatric operation and were excluded. Furthermore, patients were classified as having "severe" OI if they were prescribed the vasopressor agents midodrine or fludrocortisone. All patients who were not prescribed these agents were designated as having "moderate" OI. 
| Assessment of medical records review reliability
| Identification of comorbidity and demographic data
Study patients were characterized using data on gender, race, ethnicity, and age at the time of operation and using ICD 9 and 10 diagnosis codes to identify relevant comorbidities recorded in the medical record before bariatric surgery. Study comorbidities included T2DM, hypertension, end-stage renal disease (ESRD), sleep apnoea, coronary artery disease (CAD), and hypoglycaemia. Neuropathy was defined using the specific ICD 9 and 10 codes and the use of gabapentin with or without abnormal electromyography (EMG) test. Congestive heart failure was defined using the specific ICD 9 and 10 codes and the use of diuretics. All the ICD 9 and 10 codes are listed in Appendix S2.
| Body weight data
Available body weight data from bariatric surgery patients who returned for a follow-up visit were collected at 0, 0.3, 1, 3, 6, 9, 12, 18, 24, 36, 48, and 60 months post operation (±10% of interval, eg, 60 ± 6 months was defined as 60 months post operation).
| Evaluation of autonomic reflexes
Autonomic function test (AFT) data were extracted from the SD, but such data were only available from patients who had been referred to the VADC. The AFTs informed about the integrity of autonomic reflex arcs by evaluating blood pressure and heart rate (HR) changes in response to orthostatic stress after a 70°head-up tilt and Valsalva manoeuvre. 13 Because the charts were de-identified, only the blood pressure and HR data obtained during the head-up tilt and Valsalva manoeuvre were available for reporting. The original files needed for more in-depth analyses of autonomic function were not available.
For comparison, 30 normal controls with no autonomic dysfunction or bariatric surgery (negative controls) and 30 patients with severe autonomic neuropathy (positive controls) were included; these groups were not age or body mass index (BMI) matched because autonomic neuropathy is a neurodegenerative condition that generally affects the elderly. To determine whether any detected autonomic neuropathy was a result of vitamin deficiency, levels of vitamins B1, B6, and B12 were also analysed.
| Follow-up data
Patient retention was calculated at defined time points: 1, 2, 3, 4, and 5 years post operation. Patient retention for each patient at each time point was defined by whether recorded medical encounters existed in the VMBSD during the corresponding time interval between consecutive time points.
| Statistical analyses
Baseline preoperative comorbidity and demographic data were summarized for the subset of patients who developed OI and for the rest of the study bariatric surgery population. Discrete data were summarized as percentages, and comparisons between the groups were made using the Chi-square test. To examine the potential association between weight changes and the development of OI, we plotted the weight trends for all patients with bariatric surgery and for patients who developed OI against a rug plot of onset time for each patient identified as a case of OI. For this assessment, trends in weight for each group were expressed as excess body weight lost, in which excess weight was determined using ideal weights defined by Robinson's formula (Appendix S3). Finally, to quantify the development of new-onset OI among patients who underwent bariatric surgery, the cumulative incidence of OI was calculated using a life 
| Identification of comorbidity and demographic data
Demographic and comorbidity data of the postoperative new-onset OI patients and corresponding data from all other bariatric surgery patients are displayed in Table 1 . There were no significant differences in demographics between the groups; however, the prevalence of preoperative neuropathy and coronary artery disease was significantly higher among patients with new-onset OI. Demographic and comorbidity data from the OI patients (n = 85) were also compared between patients with OI designated as "moderate" or "severe" (Table 2) . No significant differences were observed between these groups. follow-up during the 2-and 5-year study period. The number of patients observed and lost to follow-up and the number of patients with new-onset OI during each annual time interval are shown in Table 3 . The 2-year cumulative incidence of post-bariatric OI patients adjusted by loss of follow-up was 2.2%, which is a conservative estimate. The estimated 5-year cumulative incidence adjusted by loss of follow-up was 4.2%.
| Body weight data
| Evaluation of autonomic function
AFT data were available for 21 (24 Considering that autonomic neuropathy may be associated with vitamin deficiencies, the levels of vitamins B1, B6, and B12 were determined among patients with abnormal AFTs within the first 5 years post operation; vitamin B1 and B6 levels were within normal limits, whereas vitamin B12 level was persistently low in only one patient ( Figure S1 ).
| DISCUSSION
This is the first study to estimate the cumulative incidence of OI among patients who underwent bariatric surgery. We estimated that 4.2% of patients developed OI within 5 years of their operation. Furthermore, 16 .5% of those OI cases had severe symptoms that warranted treatment with vasopressor agents.
Few studies have explored the long-term postoperative consequences of bariatric surgery outside of weight loss. Most studies were largely focused on postoperative hypoglycemia. 15, 16 A recent longitudinal study by Jakobsen et al, 10 which followed a bariatric surgery patient cohort (n = 1888) for 6 years post operation, did not report OI as a significant adverse event. Instead, the study largely focused on medications prescribed and procedures done to examine adverse events related to surgical complications, re-interventions, malnutrition, nausea, vomiting, and hypoglycaemia.
In recent years, multiple reports have documented occurrences of OI in patients after bariatric surgery [5] [6] [7] 17 ; however, the prevalence and incidence of OI in this population were unknown. The ascertainment of OI is challenging because it is considered a diagnosis of exclusion. During our review, a number of patients were identified that presented with postsurgical presyncopal symptoms. These symptoms could be related to complications of the operation (eg, acute blood loss) or the use of vasoactive medications. Hence, we needed to perform a comprehensive medical chart reviews with a prespecified The mechanism underlying post-bariatric surgery OI remains unknown. Our group 18 and others 19, 20 have shown that obesity results in an increased sympathetic (SNS) activity, decreased parasympathetic (PNS) activity, and altered baroreflex sensitivity. Previous studies have shown that bariatric surgery significantly reduces sympathetic activity, with VSG decreasing SNS as measured by direct sympathetic nerve recording at 6 and 12 months post operation. 21 Similarly, RYGB also reduces SNS at 3 and 6 months post operation. 22 Consistent with these observations, we observed patients with confirmed OI among those who underwent both VSG and RYGB.
Although the mechanisms underlying these sympatholytic actions were not completely understood, these were thought to be associated with a decrease in visceral fat 23 and leptin levels. 21 Regardless of the mechanisms involved, the reduction in SNS activity induces a decline in blood pressure in postsurgical patients, 24 which can have deleterious effects. For instance, after assuming an upright position, gravitational forces shift about 700 mL of blood volume to the lower part of the body, particularly the splanchnic circulation. 25 To compensate for decreased venous return, the SNS is activated to induce vasoconstriction. These actions are fundamental for the maintenance of orthostatic tolerance. It is noteworthy that, among post-bariatric patients with OI who had specialized autonomic testing, our group found evidence of impaired SNS activation as shown by the lack of increase in the pressor response during phase II late and phase IV of the Valsalva manoeuvre, Figure 3 . This impaired autonomic response could be explained by the presence of autonomic neuropathy.
The prevalence of neuropathy as defined by the use of gabapentin and abnormal EMG was higher in the OI population, Table 1 ; even though the prevalence of neuropathy is low (10.6% in OI and 4.5% in all RYGB patients), it could be possible that these patients may have a subclinical autonomic neuropathy unmasked by the substantial weight loss after the operation.
New-onset neuropathy associated with vitamin deficiency is less likely to explain OI considering that our cohort had normal vitamin levels during follow-up. The prevalence of coronary artery disease and diabetes mellitus was also higher in the OI group; the significance of this finding is uncertain, and further studies are needed to investigate how this impacts the development of OI after bariatric surgery.
Diabetes mellitus improves after bariatric surgery; therefore, worsening of diabetes-induced neuropathy is not expected. In our cohort, the OI group had a tendency towards a higher prevalence of sleep apnoea. Sleep apnoea is associated with increased SNS activity and attenuated baroreflex regulation; it could be possible that these patients are at higher risk of developing OI because autonomic compensatory mechanisms to standing are attenuated prior to surgery.
This hypothesis, however, need to be further studied.
The decrease in SNS could result from the substantial weight loss that occurred after the operation. Previous studies have shown that weight loss from hypocaloric diet results in reduced sympathetic activity as measured by muscle sympathetic nerve activity, which contributes to decreased orthostatic tolerance. 26 Our data in 85 postbariatric surgery subjects ( Figure 3 Many patients continued to receive health care elsewhere, as demonstrated with important losses to follow-up during the study period.
Using the life table, we attempted to account for losses to follow-up.
As with other survival analysis techniques, this approach assumes that the risk of OI among those who left the cohort is similar to the risk in Number of patients at risk for each time interval is calculated by subtracting half of the patients lost to follow-up during a given interval from the number of patients without OI at the beginning of that interval.
those who remained under observation. As patients who were lost to follow-up were by definition no longer observable, there was no practical way to fully test this assumption. Nevertheless, our study examined a large cohort of patients who underwent bariatric surgery at a major surgical centre, and we identified patients who developed OI through review of medical records and the use of strict operational case definition. We provide estimates of incidence OI post operation while taking into account losses to follow-up. Additional studies in other settings would be useful to complement our findings.
In 
